Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Kevin S Ikuta, Lucien R Swetschinski, Gisela Robles Aguilar, et al.
The Lancet (2022) Vol. 400, Iss. 10369, pp. 2221-2248
Open Access | Times Cited: 1116

Showing 1-25 of 1116 citing articles:

Findings from the Global Burden of Disease Study 2021
Christopher J L Murray
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2259-2262
Closed Access | Times Cited: 397
How Antimicrobial Resistance Is Linked to Climate Change: An Overview of Two Intertwined Global Challenges
Roberta Magnano San Lio, Giuliana Favara, Andrea Maugeri, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1681-1681
Open Access | Times Cited: 337
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Mohsen Naghavi, Dan J. Stein, Kevin S Ikuta, et al.
The Lancet (2024)
Open Access | Times Cited: 303
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Matthew S. Linz, Arun Mattappallil, Diana Finkel, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 557-557
Open Access | Times Cited: 112
Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface
Kasim Allel, Lucy Day, Alisa Hamilton, et al.
The Lancet Planetary Health (2023) Vol. 7, Iss. 4, pp. e291-e303
Open Access | Times Cited: 109
The scope of the antimicrobial resistance challenge
Iruka N. Okeke, Marlieke E.A. de Kraker, Thomas P. Van Boeckel, et al.
The Lancet (2024) Vol. 403, Iss. 10442, pp. 2426-2438
Closed Access | Times Cited: 98
Learning to Fake It: Limited Responses and Fabricated References Provided by ChatGPT for Medical Questions
Jocelyn Gravel, Madeleine D’Amours-Gravel, Esli Osmanlliu
Mayo Clinic Proceedings Digital Health (2023) Vol. 1, Iss. 3, pp. 226-234
Open Access | Times Cited: 94
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Benn Sartorius, Authia P Gray, Nicole Davis Weaver, et al.
The Lancet Global Health (2023) Vol. 12, Iss. 2, pp. e201-e216
Open Access | Times Cited: 94
Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study
Yanning Liu, Yun-Fa Zhang, Qiang Xu, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e330-e339
Closed Access | Times Cited: 87
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
David R. Shaw, Raquel Abad, Zahin Amin‐Chowdhury, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 9, pp. e582-e593
Open Access | Times Cited: 74
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Rose G Bender, Sarah Brooke Sirota, Lucien R Swetschinski, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 974-1002
Open Access | Times Cited: 74
Mechanisms and regulation of defensins in host defense
Jie Fu, Xin Zong, Mingliang Jin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Megan E. Carey, Zoe A. Dyson, Danielle J. Ingle, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 54
Recent design strategies for boosting chemodynamic therapy of bacterial infections
Junjie Zhang, Haiyang Guo, Ming Liu, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 51
Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019
Chi Zhang, X. Fu, Yi-Qi Liu, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 43, pp. 100972-100972
Open Access | Times Cited: 48
Antibiotic-induced collateral damage to the microbiota and associated infections
Laura de Nies, Carolin M. Kobras, Mathew Stracy
Nature Reviews Microbiology (2023) Vol. 21, Iss. 12, pp. 789-804
Closed Access | Times Cited: 45
Understanding bacterial pathogenicity: a closer look at the journey of harmful microbes
Jyoti Soni, Sristi Sinha, Rajesh Pandey
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 43
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Mohsen Naghavi, Tomislav Meštrović, Authia P Gray, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 868-895
Open Access | Times Cited: 43
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 41
2D Film‐Like Magnetic SERS Tag with Enhanced Capture and Detection Abilities for Immunochromatographic Diagnosis of Multiple Bacteria
Jiaxuan Li, Wanzhu Shen, Xueyan Liang, et al.
Small (2024) Vol. 20, Iss. 22
Closed Access | Times Cited: 37
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach
Marc Mendelson, Joseph A. Lewnard, Mike Sharland, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2551-2564
Closed Access | Times Cited: 36
The antibiotic resistance crisis and the development of new antibiotics
Harald Brüssow
Microbial Biotechnology (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 35
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Lorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
Clinical Microbiology and Infection (2024) Vol. 30, pp. S1-S51
Open Access | Times Cited: 34
Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Humans: Clinical Implications and Management
Ashlesha Kaushik, Helen Kest, Mangla Sood, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 33
Staphylococcus aureus colonisation and strategies for decolonisation
Pipat Piewngam, Michaël Otto
The Lancet Microbe (2024) Vol. 5, Iss. 6, pp. e606-e618
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top